|

Ixazomib Citrate Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: MLN 9708, MLN-9708, MLN9708, Ninlaro

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1
  • AIDS Malignancy Consortium1

Indications

  • Cancer2
  • Recurrent AL Amyloidosis1
  • Refractory AL Amyloidosis1
  • Skin1
  • Kaposi Sarcoma1

Duarte, California1 trial

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

City of Hope Comprehensive Cancer Center

Phase 1

San Diego, California1 trial

Trial of Ixazomib for Kaposi Sarcoma

UC San Diego

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.